Summit Global Investments

Position in NBIX — Neurocrine Biosciences Inc

CIK 1697953 BOUNTIFUL, UT

Position in NBIX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$4,959,120

+$2,708,606 QoQ

Shares Held

29,424

+72.2% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#214

of 772 holders

Holding Since

Sep 2022

16 quarters on record

Healthcare · as of Jun 30, 2026

Summit Global Investments holds $8,262,843 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (60.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	29,424	$4,959,120
2	TAK	Takeda Pharmaceutical Co Ltd	89,173	$1,429,443
3	UTHR	UNITED THERAPEUTICS Corp	1,863	$1,009,429
4	PAHC	Phibro Animal Health Corp	10,958	$344,081
5	ALKS	Alkermes plc.	6,001	$314,452
6	SUPN	Supernus Pharmaceuticals, Inc.	4,436	$206,318

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,959,120	29,424	+72.2%	Shares	Sole	2026-08-03
2026-03-31	$2,250,514	17,083	-31.1%	Shares	Sole	2026-05-07
2025-12-31	$3,517,951	24,804	-31.4%	Shares	Sole	2026-02-18
2025-09-30	$5,075,438	36,155	+214.0%	Shares	Sole	2025-11-03
2025-06-30	$1,447,446	11,516	+5.9%	Shares	Sole	2025-08-12
2025-03-31	$1,203,106	10,878	-66.1%	Shares	Sole	2025-04-07
2024-12-31	$4,376,190	32,060	-40.2%	Shares	Sole	2025-02-11
2024-09-30	$6,173,141	53,577	-31.0%	Shares	Sole	2024-10-31
2024-06-30	$10,683,329	77,601	+56.8%	Shares	Sole	2024-07-22
2024-03-31	$6,823,867	49,477	+21.5%	Shares	Sole	2024-04-29
2023-12-31	$5,366,980	40,733	+35.6%	Shares	Sole	2024-02-06
2023-09-30	$3,379,162	30,037	+1.4%	Shares	Sole	2023-10-16
2023-06-30	$2,794,203	29,631	+2.2%	Shares	Sole	2023-07-19
2023-03-31	$2,933,861	28,985	+8.7%	Shares	Sole	2023-05-04
2022-12-31	$3,186,181	26,676	+128.1%	Shares	Sole	2023-01-31
2022-09-30	$1,242,338	11,697	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.